Clinical Activebrighteningbrighteninghyperpigmentation
Tranexamic Acid
Key mechanism for Tranexamic Acid in clinical skincare.
8.5/10
Efficacy Rating
Level 1
Potency
AM/PM
Timing
Approved
Regulatory
Comedogenic Analysis
0/5
🧪
Core Specifications
INCI NameTranexamic Acid
Molecular Wt157.21 g/mol
SolubilityWater
pH Range4.5 - 6.5
Stability Profile
PhotostabilityHigh
Shelf Life24 Months
Heat IndexStable
StorageCool / Dark
Safety Integrity
PregnancySafe
IrritationLow
Skin BarrierProtective
SensitivityMinimal
Regulatory Status
FDA (US)Approved
EU (EMA)Approved
Max Conc.5%
India (CDSCO)Approved
Foundational Analysis
Key mechanism for Tranexamic Acid in clinical skincare.
Physiological Benefits
✓ Primary efficacy
Clinical Visualization
Systemic Administration Guide
1
Cleanse
Start with a clean face.
Clinical Assets
Loading scientific formulations...
Pharmacovigilance & Side Effects
⚠️ Barrier Compromise
Clinical monitoring of transepidermal water loss is recommended during initial adaptation.
⚠️ Retinoid Response
Normal phase of cellular turnover. Titrate concentration if erythema persists.